Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals. Sandoz has a portfolio of more than 950 compounds and sells its products in more than 130 countries. Key product groups include antibiotics, treatments for central nervous system disorders, gastrointestinal medicines, cardiovascular treatments and hormone therapies. Sandoz develops, produces and markets these medicines along with pharmaceutical and biotechnological active substances and anti-infectives. In addition to strong organic growth in recent years, Sandoz has made a series of acquisitions including Lek (Slovenia), Sabex (Canada), Hexal (Germany) and Eon Labs (US).

Company was acquired by Novartis AG

Acquired Companies: Oriel Therapeutics Inc., LEK Pharmaceuticals, Falcon Pharmaceuticals, Ebewe Pharma